Health, Longevity & Biohacking
Dr Chris Thompson describes pancreas-targeted GLP-1 gene-therapy concept using an insulin-promoter viral vector
Huberman Lab
Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
What was said
""They've developed a a viral vector, right, that has the gene for GLP1 in it and they're using the promoter for uh the beta cell insulin gene, right?""
Dr Chris Thompson says a company is pursuing a gene-therapy approach intended to make GLP-1 production more nutrient-responsive by placing a GLP-1 gene under control of a beta-cell insulin-gene promoter. He says the delivery method he describes involves endoscopic ultrasound-guided injection into the tail of the pancreas and that preclinical work has aimed to keep expression localised rather than systemic.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Speaker
- Dr. Chris Thompson · guest
- Programme
- Huberman Lab
- Episode
- Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
- Clip time
- 2:17:23
- Original source
- Watch the source segment →
From this episode
Huberman Lab